Lilly unveils $3.5B factory that will make retatrutide and other obesity drugsnews2026-01-30T16:00:33+00:00January 30th, 2026|Endpoints News|
Takeda ‘anticipated’ Medicare negotiations for top seller Entyvionews2026-01-29T19:06:42+00:00January 29th, 2026|Endpoints News|
Takeda is ‘not in favor’ of MFN, CEO-designate saysnews2026-01-29T18:01:01+00:00January 29th, 2026|Endpoints News|
White House postpones planned TrumpRx launch eventnews2026-01-29T17:57:02+00:00January 29th, 2026|Endpoints News|
Sanofi vows to stay committed to vaccines as portfolio takes a hitnews2026-01-29T16:18:36+00:00January 29th, 2026|Endpoints News|
Summit gets November PDUFA date for its PD-1xVEGF bispecificnews2026-01-29T15:07:25+00:00January 29th, 2026|Endpoints News|
AstraZeneca makes $15B bet on China to expand manufacturing and R&Dnews2026-01-29T13:39:17+00:00January 29th, 2026|Endpoints News|
Updated: Roche predicts its breast cancer pill could become its biggest-selling drugnews2026-01-29T12:11:54+00:00January 29th, 2026|Endpoints News|
Sanofi says its €15B dealmaking budget, R&D spend should help ease looming Dupixent patent cliffnews2026-01-29T11:46:10+00:00January 29th, 2026|Endpoints News|
ChenMed CEO warns against GLP-1s for seniorsnews2026-01-28T23:12:32+00:00January 28th, 2026|Endpoints News|
